Osaic Holdings
FBIO icon

Osaic Holdings’s Fortress Biotech FBIO Stock Holding History

Osaic Holdings’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7K Buy
9,061
+4,067
+81% +$10.5K ﹤0.01% 5909
2026
Q1 		$13.9K Sell
4,994
-2,558
-34% -$8.69K ﹤0.01% 6100
2025
Q4 		$27.6K Sell
7,552
-18,636
-71% -$53.1K ﹤0.01% 5640
2025
Q3 		$71.7K Sell
26,188
-6,191
-19% -$15.7K ﹤0.01% 5058
2025
Q2 		$60.2K Buy
32,379
+5,034
+18% +$8.72K ﹤0.01% 4913
2025
Q1 		$42.7K Buy
27,345
+829
+3% +$1.46K ﹤0.01% 4844
2024
Q4 		$53.8K Buy
26,516
+26,486
+88,287% +$48K ﹤0.01% 4649
2024
Q3 		$43 Sell
30
-1,000
-97% -$1.9K ﹤0.01% 7306
2024
Q2 		$1.76K Sell
1,030
-889
-46% -$1.61K ﹤0.01% 6646
2024
Q1 		$3.84K Sell
1,919
-37,496
-95% -$74.6K ﹤0.01% 6210
2023
Q4 		$119K Buy
39,415
+38,592
+4,689% +$102K ﹤0.01% 4311
2023
Q3 		$3.59K Hold
823
– – ﹤0.01% 6409
2023
Q2 		$6.79K Hold
823
– – ﹤0.01% 6169
2023
Q1 		$10.1K Hold
823
– – ﹤0.01% 5974
2022
Q4 		$8.29K Sell
823
-1,057
-56% -$11.7K ﹤0.01% 6037
2022
Q3 		$24K Buy
1,880
+416
+28% +$6.23K ﹤0.01% 5435
2022
Q2 		$18K Buy
1,464
+129
+10% +$1.91K ﹤0.01% 5679
2022
Q1 		$27K Buy
1,335
+708
+113% +$19.4K ﹤0.01% 5488
2021
Q4 		$24K Buy
627
+440
+235% +$19.6K ﹤0.01% 5665
2021
Q3 		$9K Sell
187
-66
-26% -$3.22K ﹤0.01% 6274
2021
Q2 		$13K Sell
253
-214
-46% -$12.9K ﹤0.01% 5903
2021
Q1 		$25K Hold
467
– – ﹤0.01% 5330
2020
Q4 		$22K Sell
467
-1,125
-71% -$48.7K ﹤0.01% 5093
2020
Q3 		$96K Buy
1,592
+800
+101% +$40.7K ﹤0.01% 3863
2020
Q2 		$31K Buy
792
+591
+294% +$22K ﹤0.01% 4518
2020
Q1 		$6K Buy
+201
New +$6.67K ﹤0.01% 5253

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's FBIO Position: Q2 2026 in Review

Osaic Holdings increased its Fortress Biotech (FBIO) stake by 81% in Q2 2026, buying an estimated $10.5K and bringing the position to 9,061 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5909.

Osaic Holdings first reported a position in FBIO in Q1 2020 and has held it in 26 quarters since. The position peaked at $119K in Q4 2023. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Osaic Holdings held 9,061 shares of Fortress Biotech worth $27.7K as of Q2 2026.
  • Osaic Holdings bought 4,067 Fortress Biotech shares in Q2 2026, an estimated $10.5K.
  • Fortress Biotech made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5909 holding.
  • Osaic Holdings first reported a position in Fortress Biotech in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Fortress Biotech position peaked at $119K in Q4 2023.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.